endocrinology
| 4 min read
| 2 min read
Aeterna has obtained an exclusive license from The University of Sheffield to IP relating to parathyroid hormone fusion polypeptides
Page 1 of 1 - 2 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe